Serial #99000439
LIVE

Serial Number

99000439

Owner

Caris MPI, Inc.

Attorney

Anne Fleeson

Filing Date

Jan 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99000439 Trademark

Serial Number: 99000439

Serial #99000439 is a trademark filed by Caris MPI, Inc. on January 16, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Caris MPI, Inc. (111 trademarks)

6655 N. MacArthur Blvd.
Irving, TX 75039

Entity Type: 03

Trademark Details

Filing Date

January 16, 2025

Registration Date

Not Registered

Published for Opposition

August 5, 2025

Goods & Services

Medical and scientific research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, next-generation sequencing, whole exome sequencing, whole transcriptome sequencing, whole genome sequencing, mass spectrometry, genetic signatures, specific genetic targets, DNA/RNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials; Medical research laboratory services; medical research laboratory services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical research laboratory services, namely, providing patient reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, including screening and early detection, prognosis, and predicting or monitoring residual disease, recurrence and/or therapeutic response for cancer patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes

medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 18, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 17, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 17, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 17, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2025 CNSA
ASSIGNED TO EXAMINER
Jun 25, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 17, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2025 NWOS
NEW APPLICATION ENTERED
Jan 16, 2025 NWAP